A new Cochrane review showed SSRIs and SNRIs outperform placebo for GAD with similar dropout rates, but questions remain ...

Mental health professionals reveal the hidden signs of anxiety disorders affecting millions of Americans, from mysterious ...

A Boston VC firm is launching a new neuroscience company with a $93M investment that aims to treat disorders including ...

You're probably familiar with the symptoms of anxiety: feeling worried, racing thoughts, and being irritable. But while being ...

Backed by Goldman Sachs, Novo Nordisk’s parent company and others, Newleos Therapeutics debuted Thursday with $94 million and ...

Boston, USA-based Newleos Therapeutics, a neuroscience company co-founded by Longwood Fund and seasoned leaders in CNS drug ...

Situationships come and go, but dried flowers last forever.

Political anxiety has become a dominant theme in our culture. We present some of the prominent features and suggestions about ...

Lexapro is an antidepressant medication commonly prescribed for anxiety. Here's how to know the best time of day to take it.

A study from SWPS University suggests that climate-related anxiety can contribute to mental health issues, particularly in ...

H.C. Wainwright analyst Pat Trucchio adjusted the price target for Cybin Inc. (NYSE:CYBN) stock, lowering it to $150.00 from the previous $190.00 while maintaining a Buy rating on the company.

Teaching anxious teens social skills, such as starting conversations, reading cues, and handling rejection, helps them build confidence and navigate social situations.